Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 2 of 1112345...10...Last »

Essay Support

Essay Support A lot of students need essay support due to the fact university tasks are usually time consuming. Would you spend some time carrying out analysis for many random essay when you could utilize that extra time to do something diffrent fully?

Read More »

Brain implant lets paralyzed man feed himself using his thoughts

A paralyzed man in Cleveland fed himself mashed potatoes for the first time in eight years, aided by a computer-brain interface that reads his thoughts and sends signals to move muscles in his arm, U.S. researchers said.

Read More »

U.S. approves Roche drug for severe form of MS

Roche’s multiple sclerosis drug Ocrevus won U.S. approval, putting the potential blockbuster back on track after a brief delay.

Read More »

EU rapid drug approval plan worries some national agencies

A push by the European Medicines Agency to speed up the approval of new drugs that show promise is running into resistance from some of the national agencies that will ultimately decide whether the medicines are worth buying.

Read More »

Trump’s FDA Head Nominee to Recuse Himself From Decisions Involving 20+ Companies

The Trump cabinet member recusals continue. Although nothing as dramatic as Attorney General Jeff Sessions’ recusal from investigating Russian interference in the 2016 presidential campaign, Scott Gottlieb – the nominee to head the Food and Drug Administration – has agreed to recuse himself from any agency decisions involving about 20 biopharma companies in his first year.

Read More »

Vertex Consolidating R&D Ops in 3 Locations, Shutters Site in Canada

Boston-based Vertex Pharmaceuticals is closing a research facility in Canada, while at the same time consolidating research-and-development operations down to three operations.

Read More »

U.S. senator launches opioid drugmaker probe

U.S. Democratic Senator Claire McCaskill seeking details from the nation’s top opioid drugmakers on their sales and marketing practices.

Read More »

Vertex CF combo succeeds in late-stage trials

Vertex Pharmaceuticals Inc. said its Kalydeco cystic fibrosis treatment given with an experimental drug demonstrated significant improvements in lung function in a pair of late-stage trials the company plans to use to seek approval of the combination therapy.

Read More »

FDA approves eczema drug Dupixent

The FDA approved Regeneron and Sanofi’s Dupixent for atopic dermatitis, a product widely seen as the most important future growth driver for the companies.

Read More »

FDA approves first-in-human trial for neural-enabled prosthetic hand system developed at FIU

Upper extremity amputees are one step closer to successfully picking up a cookie and an egg, thanks to a new advanced prosthetic system that is designed to restore sensation.

Read More »

House Republicans consider reviving healthcare push: lawmaker

Republicans in the U.S. House of Representatives are considering a renewed push to pass legislation to repeal and replace Obamacare, lawmakers and aides said after the collapse of the effort last week.

Read More »

Organogenesis Inc. Announces Acquisition of NuTech Medical

Organogenesis Inc., a commercial leader in the field of regenerative medicine, is expanding beyond wound care with the acquisition of NuTech Medical.

Read More »

Elon Musk Launches Neuroscience Startup

Elon Musk, the visionary behind SpaceX and Tesla, launched a new venture called Neuralink – a company that hopes to link humans with artificial intelligence.

Read More »

Mylan underpayment on EpiPen could exceed proposed settlement – study

The amount that drugmaker Mylan NV avoided paying the U.S. government in Medicaid rebates for its EpiPen emergency allergy treatment since 2007 likely exceeds a proposed $465 million settlement the company announced in October 2016, according to a published study by private drug pricing experts.

Read More »

Hire the very best Article Writing Services and have Good quality Content

Hire the very best Article Writing Services and have Good quality Content Article writing is the procedure of creating articles on-line for different uses. Very first, it seeks to tell the web viewers about a a number of matter, whether it be health care, well being, organization, and so on. 2nd, it plans to marketplace […]

Read More »

Hire the very best Article Writing Services and have Good quality Content

Hire the very best Article Writing Services and have Good quality Content Article writing is the procedure of creating articles on-line for different uses. Very first, it seeks to tell the web viewers about a a number of matter, whether it be health care, well being, organization, and so on. 2nd, it plans to marketplace […]

Read More »

FDA approves Tesaro’s ovarian cancer drug

The U.S. Food and Drug Administration approved Tesaro Inc.’s drug, Zejula (niraparib), for the treatment of recurrent ovarian cancer.

Read More »

Foamix’s acne drug misses main goal in key study

Foamix Pharmaceuticals Ltd. said its experimental acne treatment failed to meet one of two main goals in a late-stage study, pushing its shares down about 42 percent.

Read More »

New budget test puts UK on front line in global drug price fight

Can society afford modern medicines? It’s a question facing governments worldwide and nowhere more so than in Britain, where a new budget test due to take effect on April 1, 2017, threatens to throw up another hurdle to patients getting the drugs.

Read More »

Gilead hepatitis C drug patent faces European challenge

International groups representing doctors and patients have launched a fresh challenge to the patent on Gilead Sciences’ hepatitis C drug sofosbuvir at the European Patent Office in order to increase access to the treatment.

Read More »

Page 2 of 1112345...10...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!

Subscribe

Ad Right Bottom